The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Whole-exome sequencing in tumor samples from sequenom-wild-type, ALK negative stage IV lung adenocarcinoma (ADC) patients (p).
Enriqueta Felip
No relevant relationships to disclose
Ginevra Caratu
No relevant relationships to disclose
Daniel Silberschmidt
No relevant relationships to disclose
Pablo Martinez
No relevant relationships to disclose
Alex Martinez Marti
No relevant relationships to disclose
Susana Cedres
No relevant relationships to disclose
Nuria Murtra-Garrell
No relevant relationships to disclose
Alejandro Navarro-Mendivil
No relevant relationships to disclose
Ludmila Prudkin
No relevant relationships to disclose
Jose Jimenez
No relevant relationships to disclose
Pilar de la Morena
No relevant relationships to disclose
Mercedes Canela
No relevant relationships to disclose
Paolo Nuciforo
No relevant relationships to disclose
Hector G. Palmer
No relevant relationships to disclose
Ana Vivancos
No relevant relationships to disclose